Gerald Posner
Pulitzer finalist, investigative journalist and author
Gerald Posner has spent decades investigating the pharmaceutical industry's darkest corners. In his Beyond Gender appearance, he draws a stark parallel between the opioid crisis — which devastated communities across Ireland and the world — and the financial machinery now driving the trans medical industry. His question is blunt: who profits when children become lifelong patients, and why won't journalists ask it?
Gerald Posner is one of America's most tenacious investigative journalists — a Pulitzer Prize finalist and former attorney whose career has been defined by following the money through some of history's most consequential stories: assassination conspiracies, Nazi war crimes, and, most recently, the pharmaceutical industry. His 2020 book Pharma: Greed, Lies, and the Poisoning of America traced how drug companies corrupted regulators, captured physicians, and engineered the opioid epidemic that killed hundreds of thousands of people. That work established him as one of the foremost voices on how medical-industry profit motives can override patient safety — and why mainstream journalism so often fails to sound the alarm until the damage is done.
In the Beyond Gender episode Why Journalists Won't Investigate the Trans Medical Industry (episode 15, May 2025), Posner joins Stella O'Malley, Mia Hughes, and Dr Bret Alderman to apply exactly that investigative lens to gender medicine. The parallels he draws are uncomfortable and precise: pharmaceutical companies, medical organisations, and advocacy groups forming a financial ecosystem that benefits from an expanding pool of lifelong patients — patients who, in many cases, are children. He presses the question his opioid reporting once demanded: why is the press, which eventually pursued that story, so reluctant to investigate gender medicine with the same rigour?
For Irish listeners, the questions land close to home. Ireland's gender medicine landscape has expanded rapidly, with the HSE's national service under sustained pressure and private providers moving into the gaps. Irish media has largely declined to scrutinise the commercial interests at play. Posner's framework — examine the money, map the incentives, ask who benefits from a growing patient population — is one that Irish journalists, clinicians, and policymakers urgently need to apply.
His appearance on Beyond Gender is a reminder that scepticism of a medical industry is not a fringe position. It is the baseline expectation of serious journalism — and one that took far too long to arrive during the opioid crisis. Posner argues, compellingly, that Ireland and the wider world cannot afford to wait that long again.
